Cross-cultural validation of the IRB Researcher Assessment Tool: Chinese Version

Author:

Liu Xing,Wu Ying,Yang Min,Li Yang,Hahne Jessica,Khoshnood Kaveh,Coleman Linda,Wang Xiaomin

Abstract

Abstract Background Using an effective method for evaluating Institutional Review Board (IRB) performance is essential for ensuring an IRB’s effectiveness, efficiency, and compliance with applicable human research standards and organizational policies. Currently, no empirical research has yet been published in China evaluating IRB performance measures by the use of a standardized tool. This study was therefore conducted to develop a Chinese version of the IRB Researcher Assessment Tool (IRB-RAT), assess the psychometric properties of the Chinese version (IRB-RAT-CV), and validate the tool for use in China. Methods In this cultural adaptation, cross-sectional validation study, the IRB-RAT-CV was developed through a back-translation process and then distributed to 587 IRB staff members and researchers in medical institutions and schools in Hunan Province that review biomedical and social-behavioral research. Data from the 470 valid questionnaires collected from participants was used to evaluate the reliability, content validity, and construct validity of the IRB-RAT-CV. Results Participants’ ratings of their ideal and actual IRB as measured by the IRB-RAT-CV achieved Cronbach's alpha 0.989 and 0.992, Spearman-Brown coefficient 0.964 and 0.968, and item-total correlation values ranging from 0.631 to 0.886 and 0.743 to 0.910, respectively. Conclusion The IRB-RAT-CV is a linguistically and culturally applicable tool for assessing the quality of IRBs in China.

Funder

Major Scientific and Technological Projects for Collaborative Prevention and Control of Birth Defects in Hunan Province

NIH Fogarty International Center Masters Level Bioethics Program at Central South University in Changsha, China

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Health(social science),Issues, ethics and legal aspects

Reference40 articles.

1. WMA Declaration of Helsinki - Ethical Principles for Medical research involving human subjects. 64th WMA General Assembly, Fortaleza, Brazil, October 2013. https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/. Accessed 21 Aug 2021.

2. ICH Harmonised Tripartite Guideline Guideline for Good Clinical Practice E6(R1). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2016. http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html. Accessed 21 August 2021.

3. World Health Organization. Standards and operational guidance for ethics review of health-related research with human participants. World Health Organization. 2011. https://apps.who.int/iris/handle/10665/44783. Accessed 21 Aug 2021.

4. International Ethical Guidelines for Health-related Research Involving Humans, Fourth Edition. Geneva. Council for International Organizations of Medical Sciences (CIOMS). 2016. https://cioms.ch/publications/product/international-ethical-guidelines-for-health-related-research-involving-humans/. Accessed 21 Aug 2021.

5. Yarborough M. Do we really know how many clinical trials are conducted ethically? Why research ethics committee review practices need to be strengthened and initial steps we could take to strengthen them. J Med Ethics. 2021;2020(47):572–9.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3